ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 196 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,578,000 | +69.7% | 34,065 | -10.7% | 0.18% | +54.4% |
| Q1 2019 | $930,000 | +65.2% | 38,144 | -3.5% | 0.11% | +39.0% |
| Q4 2018 | $563,000 | -20.6% | 39,519 | -15.3% | 0.08% | -16.3% |
| Q3 2018 | $709,000 | +90.6% | 46,669 | +110.5% | 0.10% | +71.9% |
| Q2 2018 | $372,000 | -100.0% | 22,170 | -52.8% | 0.06% | -53.3% |
| Q1 2018 | $766,632,000 | +32.9% | 46,975 | +4.2% | 0.12% | +31.2% |
| Q4 2017 | $576,960,000 | +882.3% | 45,075 | +844.0% | 0.09% | +830.0% |
| Q3 2017 | $58,733,000 | +47.0% | 4,775 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $39,967,000 | -6.4% | 4,775 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $42,689,000 | – | 4,775 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |